Opportunity Information: Apply for PAR 18 749
The National Institutes of Health (NIH), through the National Institute on Aging (NIA), announced a discretionary grant opportunity titled "Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed)" under funding opportunity number PAR 18-749 (CFDA 93.866). This opportunity is designed to support collaborative, team-based efforts that directly address persistent problems in how aging research studies recruit participants and keep them engaged over time, with a particular emphasis on improving diversity and representation in research participation. The grant mechanism is an R24 resource-related project, which generally means the focus is on building tools, infrastructure, and practical resources that will benefit the broader research community rather than running an intervention trial. As stated in the title, clinical trials are not allowed under this announcement.
At its core, the program aims to close gaps in both methods and outcomes related to recruitment and retention. The expectation is that funded teams will do more than simply restate common barriers; they should generate workable, evidence-informed improvements that can be adopted and scaled. The announcement emphasizes developing a "research resource" that advances high-yield recruitment processes, meaning approaches that reliably bring in participants efficiently and ethically. It also calls for breakthrough ideas and new concepts for recruitment and retention, suggesting that applicants are encouraged to move beyond routine advertising and enrollment tactics and instead test and refine creative, community-responsive strategies. Another central theme is strengthening outreach and community engagement, which typically involves building sustained relationships with community organizations, local leaders, and trusted institutions, and integrating community feedback into how studies are designed and presented. The opportunity also highlights improved communication strategies, which can include clearer messaging about study goals and expectations, culturally and linguistically appropriate materials, transparency about risks and benefits, and communication practices that foster trust and reduce dropout.
A defining deliverable for this initiative is demonstration. Teams are expected to show that their proposed improvements actually work by engaging a large, diverse population. The primary outcome is not a traditional clinical endpoint, but rather the creation or development of a population of diverse community members who are ready and prepared to participate in NIA-funded clinical research studies in the future. In practical terms, this means building a robust, engaged pipeline of potential participants, improving readiness and willingness to enroll, and establishing processes that make participation more accessible and sustainable. The intent is to leave behind a durable resource that other NIA investigators can leverage to improve enrollment diversity and retention in later studies.
Eligibility is broad across U.S.-based organizations and includes many public and private entities. Eligible applicants include state, county, and city governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (so long as they are not institutions of higher education, where applicable); for-profit organizations (other than small businesses); small businesses; and other eligible organizations. The announcement explicitly calls out additional eligible applicant categories that align with the diversity and community engagement aims of the program, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, tribal governments other than federally recognized, and U.S. territories or possessions.
Foreign eligibility is clearly restricted. While the text references "Non-domestic (non-U.S.) Entities (Foreign Organizations)" in a way that can look confusing at first glance, the announcement clarifies that non-domestic (non-U.S.) entities or foreign institutions are not eligible to apply. In addition, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by the NIH Grants Policy Statement are not allowed. In short, the work and the applicant organization must be U.S.-based, and the project cannot include foreign components under NIH definitions.
Administrative details included in the source indicate the opportunity was created on 2018-04-10, with an original closing date listed as 2021-01-25. The award ceiling and expected number of awards are not specified in the provided excerpt, which typically means applicants would need to consult the full FOA text and related NIH budgeting guidance to understand typical award sizes, project periods, and review considerations. Overall, the opportunity is geared toward building and validating practical recruitment and retention resources that can measurably strengthen diversity and sustained participation in aging research, leaving the field with improved methods, stronger community ties, and a ready pool of diverse participants for future NIA-funded clinical studies.Apply for PAR 18 749
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2018-04-10.
- Applicants must submit their applications by 2021-01-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Pre-Solicitation Notice for Bioethics and Disability Report Series
Previous opportunity: 2018 South Africa
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 749
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 749) also looked into and applied for these:
| Funding Opportunity |
|---|
| Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional) Apply for PA 18 753 Funding Number: PA 18 753 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Next-Generation Biologics for Sustained HIV Remission (R01 Clinical Trial Not Allowed) Apply for RFA AI 18 017 Funding Number: RFA AI 18 017 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trials Not Allowed) Apply for PA 18 754 Funding Number: PA 18 754 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) Apply for PAR 18 755 Funding Number: PAR 18 755 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Curricular or Training Activities in Skills Development (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 759 Funding Number: PA 18 759 Agency: National Institutes of Health Category: Health Funding Amount: $80,000 |
| Development of Curricular or Training Activities in Laboratory Safety (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 758 Funding Number: PA 18 758 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Curricular or Training Activities in Rigor and Transparency to Enhance Reproducibility (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 756 Funding Number: PA 18 756 Agency: National Institutes of Health Category: Health Funding Amount: $80,000 |
| Administrative Supplements to NIGMS Predoctoral Training Grants for the Development of Activities to Prepare Trainees for Careers in the Biomedical Research Workforce (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 757 Funding Number: PA 18 757 Agency: National Institutes of Health Category: Health Funding Amount: $80,000 |
| Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed) Apply for RFA HG 18 001 Funding Number: RFA HG 18 001 Agency: National Institutes of Health Category: Health Funding Amount: $700,000 |
| Novel Nucleic Acid Sequencing Technology Development (R43/R44 Clinical Trial Not Allowed) Apply for RFA HG 18 003 Funding Number: RFA HG 18 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed) Apply for RFA HG 18 002 Funding Number: RFA HG 18 002 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed) Apply for PAR 18 760 Funding Number: PAR 18 760 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) Apply for PAR 18 761 Funding Number: PAR 18 761 Agency: National Institutes of Health Category: Health Funding Amount: $499,000 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) Apply for PAR 18 763 Funding Number: PAR 18 763 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) Apply for PAR 18 762 Funding Number: PAR 18 762 Agency: National Institutes of Health Category: Health Funding Amount: $499,000 |
| Targeted In Vivo Delivery of Gene Therapeutics for HIV Cure (R01 Clinical Trial Not Allowed) Apply for RFA AI 18 016 Funding Number: RFA AI 18 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Small Research Grant Program for the Next Generation of Researchers in Basic Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed) Apply for RFA AG 19 003 Funding Number: RFA AG 19 003 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Small Research Grant Program for the Next Generation of Clinical Researchers in Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (R03 Clinical Trial Optional) Apply for RFA AG 19 002 Funding Number: RFA AG 19 002 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required) Apply for RFA AI 18 015 Funding Number: RFA AI 18 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) Apply for RFA HL 19 023 Funding Number: RFA HL 19 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 749", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
